Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says
This article was originally published in The Gray Sheet
Executive Summary
A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2